Baxter CEO's compensation dipped in 2009

Baxter International chairman and CEO Robert Parkinson saw his compensation fall to under $14.4 million last year--down from $14.8 million in 2008, according to regulatory filings.

Parkinson's salary was just over $1.342 million--only slightly up from 2008's $1.339 million. Parkinson's performance bonus fell $2.5 million, which represented a decrease of 8 percent compared with his 2008 cash bonus.

In the filing, the company attributes Parkinson's compensation to "strong company and individual performance in 2009 and 2008." It also "reflects the role he plays in establishing Baxter's strategic agenda and long-range plan, meeting the challenges that arise in the day-to-day operations of a company as large and diverse as Baxter and leading the company in a challenging global economic and regulatory environment."

- check out the SEC filing

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.